The Respiratory Effectiveness Group (REG) is a not-for-profit initiative established by international experts in real-life and comparative effectiveness research in respiratory medicine.

The Group sets quality standards in the field of real-life research and improves understanding of the optimum role of real-life data to inform meaningful clinical practice guidelines, drug licensing and post-marketing surveillance processes and improved patient care.

Why is Respiratory Research important?


Research or medical professional? Get involved with ground-breaking research as part of our expert international team.

Pharmaceutical or medical company? Support REG and discover the exclusive benefits and insights offered to our supporters.
About Us
Find out a bit more about our group, what makes us tick and how you can get involved

How We Work

Working Groups
Real-life research has utility across a number of core areas of respiratory research.
Research Groups
All studies are disseminated through the REG website, congress abstracts and peer review journal publications for the benefit of all working in respiratory medicine.
The REG Team
REG is supported by a small team of professionals who aim to further the aims and objectives of the organisation and deliver value in their assigned role.

Latest News from our Blog

Matched cohort study of therapeutic strategies to prevent preschool wheezing/asthma attacks

A recently published retrospective cohort study, supported by REG and Optimum Patient Care (OPC), has found no evidence that initiating ...
Read More

2018 Summer Newsletter

In this edition you can find details of our upcoming meetings at ERS, a team update, recent REG publications as ...
Read More

More testing for alpha-1 antitrypsin deficiency is needed in the UK

Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and the third leading cause of death worldwide ...
Read More

More News

REG Blog